Associated Papers
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis.
Maruyama H et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2019
29543226 (PubMed )
Supplement: 41436_2018_239_MOESM1_ESM.pdf
Select a paper to view details